82 results
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
10 Jun 24
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
8:45am
-profit kidney care company. She served on the Quality, Safety & Patient Experience and the Government & Compensation Executive & Strategy committees
8-K
EX-99.1
ICU
SeaStar Medical Holding Corp
14 May 24
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
4:05pm
that is evaluating the safety and efficacy of our Selective Cytopheretic Device Adult (SCD-ADULT) in the significantly larger U.S. adult AKI patient population … with clinical results showing safety and probable clinical benefit to critically ill children with AKI who have few treatment options. The U.S. addressable
8-K
EX-99.1
1kic xsw0
17 Apr 24
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
4:01pm
424B3
zjadb0qd8hgx4mbe
5 Mar 24
Prospectus supplement
5:08pm
424B3
6mocd2mh6 ki2d3kqh8d
5 Mar 24
Prospectus supplement
5:06pm
424B3
k9pdqjsnqa
5 Mar 24
Prospectus supplement
4:59pm
424B3
zq1q euyup9
5 Mar 24
Prospectus supplement
4:57pm
8-K
EX-99.1
cgnxuj26cq96 o3
22 Feb 24
FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
8:00am
8-K
EX-10.1
zi0kbxug3cer
30 Jan 24
SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market
9:18am
8-K
EX-99.1
1mqpb85
21 Nov 23
SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update
6:04pm
424B3
h38idge21o6 frb
6 Oct 23
Prospectus supplement
1:08pm
424B3
i47u8r565gc
6 Oct 23
Prospectus supplement
1:06pm
424B3
s11kkjh 3sw9s34bxg2
6 Oct 23
Prospectus supplement
1:04pm
424B3
vvl4m lh8n
6 Oct 23
Prospectus supplement
12:59pm
8-K
EX-99.1
dfxc2s7he 4h6j3
3 Oct 23
Company to finalize labeling with FDA Approvable Letter expected within a month
4:07pm